Skip to content
Research Article Open access CC BY 3.0

Endothelial Dysfunction and Cardiovascular Disease: Critical Target for Cell-Based Therapies

Namita M. Varudkar, Heidi Emrani, Steven N. Ebert, Atul Madan

Journal of Advances in Medicine and Medical Research · pp. 3042–3058 · Published 13 Mar 2014

10.9734/BJMMR/2014/7329

Abstract

This review briefly summarizes how cell-based therapeutic interventions are being developed and applied to treat endothelial dysfunction (ED) as a critical clinical target. ED directly contributes to the onset and prognosis for all of the major forms of cardiovascular diseases, including atherosclerosis, pulmonary artery hypertension, peripheral hypertension, stroke, myocardial infarction and congestive heart failure. Current pharmacological therapies used to treat ED are discussed and compared with newer strategies employing endothelial progenitor cells (EPCs) and other stem cells for tissue repair/regeneration therapies. Cell-based therapies to treat ED are still largely experimental but they are emerging in the clinic and represent a promising avenue for new interventional options to combat cardiovascular disease and improve patient outcomes.

Endothelium stem cells cardiovascular disease therapy endothelial progenitor Cells angiogenesis myogenesis Angiomyogenesis.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

6

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.